CURRENT GUIDELINES IN DEVELOPMENT
CARI Guidelines mission is to improve the quality of care and outcomes for patients with kidney disease in Australia & New Zealand by facilitating the development and implementation of trustworthy clinical practice guidelines based on the best available evidence and effectiveness.
COVID19 guidelines
Evidence summary for infection control for COVID19 in dialysis units
- A/Prof Meg Jardine, The University of New South Wales; Prof Eugene Athan, Deakin University
Evidence summary for kidney or kidney-pancreas transplant recipients
- Chair: A/Prof Germaine Wong, The University of Sydney
Kidney Stones Update
Chairs: Dr Hicham Hassan, The University of Wollongong
Co-covener: Prof Matthew Jose, University of Tasmania
Management of Chronic Kidney Disease in Indigenous Australians
- Chairs: A/Prof Richard Phoon, The University of Sydney
Management of Chronic Kidney Disease in Māori Aotearoa CARI Guideline
Co-covenor: Prof Suetonia Palmer, University of Otago
Co-convenor: Dr Curtis Walker, Mid Central District Health Board
Cholesterol-lowering therapy in chronic kidney disease living guideline
Co-convenor: Prof David Johnson, The University of Queensland
Co-convenor: Prof Rob Walker, University of Otago
Methods convenor: Prof Suetonia Palmer, University of Otago